Medical imaging offers an invaluable reading grid on living organisms for biomedical research, the development of therapeutic innovations and the practice of medicine. As a source of innovation, medical imaging will play an important role in the development of predictive and personalized medicine, thus integrating into most multidisciplinary research programs.
PASREL-Imagerie’s ambition is to structure and federate research and business stakeholders in the Ile-de-France drug and medical imaging sectors around a cutting-edge medical imaging platform that can be accessed by all.
The goals of PASREL-Imagerie are twofold:
Implementation of PASREL-Imagerie is subsidised by the Ile-de-France Region.
PASREL-Imagerie plays a role throughout the value chain of innovative drugs in order to accelerate and derisk their market launch:
Contact us at pasrel@cea.fr so that we can identify with you how PASREL-Imagerie can assist you.
PASREL-Imagerie supports imaging manufacturers by:
Contact us at pasrel@cea.fr so that we can identify with you how PASREL-Imagerie can assist you.
Thanks to its governance, which includes a Sector Committee made up of 50% representatives from the industrial sector, as well as representatives of all stakeholders (researchers, clinicians, teachers, etc.), PASREL-Imagerie encourages and facilitates dialogue to strengthen the coherence of the products and services that are developed and to optimize the R&D phases.
The Sector Committee:
Thanks to training sessions (case studies, focus on a particular technology, etc.) and events (science days, open houses, workshops, etc.) designed in collaboration with manufacturers, PASREL-Imagerie brings together all the stakeholders around hot scientific topics, thus, fostering their increased expertise.
PASREL-Imagerie grants access to the technical platforms of four CEA research centers that are located in the Paris-Saclay perimeter:
PASREL-Imagerie thus brings together 33 technical platforms and 10 laboratories or joint research units that have been collaborating on ambitious projects for many years and have now reached the necessary maturity to open up more widely to industrial partners.